Anticonvulsant activity of 1-alkyl-4-substituted 3,5-pyrazolidinediones.
D000478:Alkylation; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004597:Electroshock; D006834:Hydrazines; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008314:Malonates; D051379:Mice; D009461:Neurologic Manifestations; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010672:Phenytoin / Q000009:adverse effects / Q000494:pharmacology; D011720:Pyrazoles / Q000009:adverse effects / Q000138:chemical synthesis / Q000494:pharmacology*; D013055:Spectrophotometry, Infrared; D013388:Succinimides / Q000009:adverse effects / Q000494:pharmacology; D013997:Time Factors
D000927:Anticonvulsants; D006834:Hydrazines; D008314:Malonates; D011720:Pyrazoles; D013388:Succinimides; D010672:Phenytoin; D010433:Pentylenetetrazole